Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in IFRX — InflaRx N.V.

CIK 1595888 NEW YORK, NY
Back to IFRX Full portfolio

Position in IFRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$320,826
+$320,826 QoQ
Shares Held
143,226
Ownership
0.097%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 62 holders
Holding Since
Jun 2023
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IFRX Over Time

Shares Held

Position Value (USD)

Derivatives in IFRX

reported options exposure · as of Jun 30, 2026
CallValue
$208,768
CallShares
93,200
PutValue
$30,016
PutShares
13,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names. IFRX ranks #146 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in IFRX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $208,768 93,200
2026-06-30 $320,826 143,226
2026-06-30 $30,016 13,400
2026-03-31 $30,931 34,600
2025-12-31 $13,635 13,500
2025-12-31 $183,531 181,716
2025-09-30 $114,778 85,656
2024-03-31 $71,633 46,515
2023-06-30 $155,613 34,891